Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2007 by Retina Associates, Kansas City.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Retina Associates, Kansas City
ClinicalTrials.gov Identifier:
NCT00516464
First received: August 14, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2008
  Estimated Primary Completion Date: No date given